Tolerance and Prebiotic Activity of Arabinoxylan-Oligosaccharides in Healthy Subjects

Catholic University (KU) of Leuven

Status and phase: Completed; Phase 4

Conditions: Healthy

Treatments: Dietary Supplement: arabinoxylan-oligosaccharides (AXOS)

Study type: Interventional

Funder types: Other

Identifiers

NCT00852813

AXOS 002

Details and patient eligibility

About

The purpose of the study is to evaluate the tolerance of a higher dose of arabinoxylan-oligosaccharides (AXOS) and their prebiotic activity in healthy subjects.

Enrollment: 20 patients

Sex: All

Ages: 18 to 45 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• healthy
• 18-45 years
• regular eating pattern

Exclusion criteria

• gastrointestinal complaints
• antibiotic intake
• medication influencing gut transit or microbiota
• abdominal surgery
• pregnancy

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Single Blind